Port-wine Stain

1033 Users are discussing this topic

PatientPlus articles are written by UK doctors and are based on research evidence, UK and European Guidelines. They are designed for health professionals to use, so you may find the language more technical than the condition leaflets.

See also: Port-wine Stain written for patients

Synonyms: PWS, naevus flammeus

This is the most common type of capillary malformation and is a congenital malformation of the superficial blood vessels of the dermis.

It is a deep pink or red patch present at birth and grows in size as the child grows. 0.3-5% of newborns are affected.[1] There is an equal sex distribution.

The lesion may darken to purple as the child grows and persists throughout life. It can occur anywhere but most often occurs unilaterally on the face or neck. The lesion is flat; the overlying skin is normal. Later in life more papular lesions can occur within the patch. There are frequently emotional and social problems for the affected person because of the stigma of such a visible disfigurement.

Rarely, acquired forms can occur at any age after birth. The cause has not been elucidated but trauma, chronic ultraviolet (UV) exposure, hormonal influences, infections, solid brain tumour and various internal vascular disorders have been suggested as possible associations.[2] 

NEW - log your activity

  • Notes
    Add notes to any clinical page and create a reflective diary
  • Track
    Automatically track and log every page you have viewed
  • Print
    Print and export a summary to use in your appraisal
Click to find out more »

Pathogenesis

The condition results from abnormal ectasia (dilation) of papillary dermal capillaries and post-capillary venules. Evidence suggests that a deficiency in perivascular nervous tissue results in reduction in vascular tone, leading to dilation. There appear to be two sub-types which differ in morphology. Type 1 (superficial, tortuous, dilated end-capillary loops in the superficial papillary dermis) appears to be more sensitive to laser therapy than type 2 (ectatic vessels in the superficial horizontal vascular plexus). There is evidence that vascular endothelial growth factor and its receptor may be involved in the pathogenesis.[3] 

Most involve the head and the neck. On the face, 45% are restricted to just one of the three regions of the trigeminal nerve, with 55% crossing to more than one area. Those that do are often bilateral.[4] 

PORT WINE STAIN (1)

This lesion on the face is rather darker in an older person. It is flat and the distribution shows why it is such a social embarrassment.

PORT WINE STAIN

This is not so dark as the other lesions but may develop with time. It is in the distribution of the mandibular segment of the trigeminal nerve.

Natural history

  • The lesion remains present for life and has no tendency toward involution.
  • In early life, they are flat and usually clearly demarcated. The colour does not correlate with depth or diameter of capillaries. Blanching on pressure is variable. They are usually unilateral with a clear demarcation at the midline.
  • The lesions may change from pink in infancy to red in early adulthood to deep purple during middle age.
  • Nodular vascular lesions may develop, usually in adulthood.
  • Pyogenic granulomas with bleeding may develop, even in childhood.
  • Later in life, the vasculature dilates and the lesions may evolve into a raised, thickened plaque with a cobblestone contour. This may occur in up to 65% of facial lesions during adulthood.
  • Lobulated capillary haemangiomas (pyogenic granulomas) may form, especially with intra-oral lesions.

The diagnosis of a port-wine stain is usually clear but there may be concern that it is not an isolated lesion but part of a syndrome (see 'Associated diseases', below). Other conditions to consider include:

Infantile haemangioma

Infantile haemangioma is a benign vascular neoplasm. Occasionally they may cause pressure effects on adjacent vital structures, ulcerate, bleed or cause high-output cardiac failure.

Proteus' syndrome[6] 

This is a disorder in which irregular asymmetric overgrowth of multiple body tissues occur. Severe cases involve large areas of the body (the 'Elephant Man' is the most famous patient to have had this condition) but more localised forms can resemble capillary malformations.

Rubinstein-Taybi syndrome[7] 

Rubenstein-Taybi syndrome is characterised by broad thumbs and big toes, short stature, general learning disability and capillary naevus of the forehead or nape in over 50% of patients.

Morphoea[8]

Localised morpohea may mimic an acquired port-wine stain.

Miscellaneous

Other conditions which may need to be considered depending on the clinical presentation include non-accidental injury, forceps injury, insect-bite reaction, telangiectatic haemangioma and unilateral nevoid telangiectasias.[5] 

Glaucoma[5] 

There is an association between port-wine stains involving the eyelids and glaucoma. Glaucoma may occur in about 10% of facial port-wine stains but the figure rises to between a quarter and a half when both the ophthalmic and maxillary divisions are involved.

Spinal abnormalities[9] 

Neural tube defects and tethered spinal cord may be associated conditions. Lumbar skin changes such as acrochordons (skin tags), an abnormal tuft of hair (fawn's tail) and lipomas have been observed.

Sturge-Weber syndrome

Port-wine stain, in association with ocular intracranial angiomas, causes blindness, focal epilepsy, hemiplegia or general learning disability - Sturge-Weber syndrome.[10] The lesion is clearly unilateral and in the trigeminal area, usually in the ophthalmic division. There are ipsilateral capillary malformations on the leptomeninges and cerebral cortex. The condition may be bilateral.

Cobb's syndrome

This includes cutaneomeningospinal angiomatosis. A lesion in the skin overlying the spine is associated with vascular malformations in the underlying spinal meninges. There may be pressure on the spinal cord or nerves, bone erosion and subarachnoid haemorrhage.

Klippel-Trénaunay syndrome

This is also known as angio-osteo-hypertrophy syndrome.[11] Klippel-Trénaunay syndrome is an association of a port-wine stain, varicose veins and hypertrophy of a limb. The lower limbs are involved in 95% of patients and it is unilateral in 85%. Most babies are asymptomatic at birth but have problems later in childhood. Complications include:

  • Varicose veins with venous thrombosis and pulmonary embolism.
  • Bleeding from varices, the rectum, or the bladder.
  • Skin ulceration.
  • Increased sweating overlying the lesion.
  • Leg circumference or length discrepancy with resultant scoliosis.
  • Oedema and recurrent infections.

Parkes Weber's syndrome

Parkes Weber's syndrome consists of arteriovenous (AV) malformation in addition to those of the Klippel-Trénaunay syndrome. AV fistulae are usually diffuse and ablation is difficult. Most children present in childhood with an enlarged, warm extremity. The prognosis is worse than with Klippel-Trénaunay syndrome.

Wyburn-Mason's syndrome[12] 

This is also called unilateral retinocephalic syndrome and also Bonnet-Dechaume-Blanc syndrome. There are facial port-wine stains with unilateral AV malformation of the retina and the intracranial optic nerves. Lesions may occur anywhere on the face and there may be facial hypertrophy or occasional involvement of the optic chiasm, the hypothalamus, the midbrain and the basal ganglia, with associated general learning disability or neurological features.

  • If Sturge-Weber syndrome is suspected, MRI scan of the brain is required. In very early life, results may give false reassurance.[13] 
  • Photoacoustic imaging can be used to give information relating to the depth of the lesion and its vasculature.[14] Cerebral angiography is also occasionally used.
  • Optical coherence tomography (a technique which acquires optical signals and can identify very small structures just under the surface of the skin) has been adopted for the diagnosis of port-wine stains.[15]
  • A number of other newly developed optical and scanning devices are becoming available.[16] 
  • There is no consensus as to whether patients with isolated capillary malformations require imaging to exclude cerebrovascular abnormalities.
  • Regular ophthalmic checks to exclude glaucoma should be carried out in the first three years of life.

Refer as young as possible, usually around 1 year old, to a centre which has the laser and anaesthetic facilities. Some centres may treat earlier. Early referral is recommended for facial lesions in view of the cosmetic impact and to rule out associated conditions such as Sturge-Weber syndrome and glaucoma.[17] 

  • The tunable pulsed dye laser (PDL) emits light at 585 nm which is preferentially absorbed by haemoglobin.[1] 
  • The length of the pulse of light (450 microseconds) is just long enough to heat small vessels but not the surrounding tissue. This results in destruction of the blood vessels without any scarring. The results are best in babies or infants.
  • Treatment is painful and, in small children, requires a general anaesthetic but small infants have smaller areas to be treated (before they have grown). Local anaesthetic is helpful.[18]
  • The treatment is tedious, time-consuming and expensive and may not be universally available without charge on the NHS.
  • Few patients achieve total clearance and some do not respond at all.[19] 
  • Several treatments may be required, spaced at 2-3 monthly intervals; postoperatively, patients are usually advised to avoid the sun, avoid injury and use an emollient.
  • One study recommended a 'double-pass' technique for patients with capillary malformations resistant to previous laser therapy.[20] 
  • Another study reported that laser speckle imaging (a method of assessing the degree of scatter of laser beams after they have come into contact with tissue) after laser treatment showed areas of incomplete photocoagulation in some patients. The authors recommended immediate re-coagulation in these cases.[21] 
  • Surgical excision with or without cosmetic reconstruction may be required for lesions resistant to laser therapy.[22] 

Current research is looking at the added efficacy of PDL with topical imiquimod., exogenous heat or intravenous porphyrin derivatives.[23][24]

PDL laser is sometimes used in conjunction with a potassium titanyl phosphate (KTP) laser.[1]  

Combined selective photothermolysis and imiquod is being explored as an effective option.[23] 

Cosmetic camouflage can be useful in hiding the area. It may be prescribed on an FP10. Tattooing of the area with skin-coloured pigment is occasionally carried out.

Hyperpigmentation is usual in treated areas but this is transient. Permanent hypopigmentation may occur in treated areas. Pyogenic granuloma in treated areas has been described.[25]

It has been said that failure to treat can result in considerable psychological morbidity but this has been challenged and one study suggested that further research is required.[26]

Eczematous dermatitis similar to stasis dermatitis can occasionally develop. It is usually responsive to topical steroids or calcineurin inhibitors but often recurs once treatment is stopped.[27] 

The lesion is permanent during life and in some may become a major cosmetic disability. Laser treatment can produce good results but complete clearance is rare. Research to develop treatments that will completely eradicate the lesion is ongoing.

Further reading & references

  1. Izikson L, Nelson JS, Anderson RR; Treatment of hypertrophic and resistant port wine stains with a 755 nm laser: a case series of 20 patients. Lasers Surg Med. 2009 Aug;41(6):427-32. doi: 10.1002/lsm.20793.
  2. Kulac M, Karaca S, Acar M, et al; Acquired port-wine stain related to acoustic neuroma. Clin Exp Dermatol. 2006 Jan;31(1):30-2.
  3. Vural E, Ramakrishnan J, Cetin N, et al; The expression of vascular endothelial growth factor and its receptors in port-wine stains. Otolaryngol Head Neck Surg. 2008 Oct;139(4):560-4. doi: 10.1016/j.otohns.2008.07.015.
  4. Neligan P et al; Plastic Surgery: Volume One: Principles, 3rd ed.
  5. Jackson S et al; Differential Diagnosis for the Dermatologist, 2012
  6. Hoeger PH, Martinez A, Maerker J, et al; Vascular anomalies in Proteus syndrome. Clin Exp Dermatol. 2004 May;29(3):222-30.
  7. Kumar S, Suthar R, Panigrahi I, et al; Rubinstein-Taybi syndrome: Clinical profile of 11 patients and review of literature. Indian J Hum Genet. 2012 May;18(2):161-6. doi: 10.4103/0971-6866.100751.
  8. Nijhawan RI, Bard S, Blyumin M, et al; Early localized morphea mimicking an acquired port-wine stain. J Am Acad Dermatol. 2011 Apr;64(4):779-82. Epub 2010 Sep 17.
  9. Sardana K, Gupta R, Garg VK, et al; A prospective study of cutaneous manifestations of spinal dysraphism from India. Pediatr Dermatol. 2009 Nov-Dec;26(6):688-95. doi: 10.1111/j.1525-1470.2009.01014.x.
  10. Sturge-Weber Syndrome, SWS; Online Mendelian Inheritance in Man (OMIM)
  11. Klippel-Trenaunay-Weber Syndrome; Online Mendelian Inheritance in Man (OMIM)
  12. D'Souza D; Wyburn-Mason syndrome, Radiopaedia.org, 2014
  13. Adams ME, Aylett SE, Squier W, et al; A spectrum of unusual neuroimaging findings in patients with suspected Sturge-Weber syndrome. AJNR Am J Neuroradiol. 2009 Feb;30(2):276-81. doi: 10.3174/ajnr.A1350. Epub 2008 Dec 2.
  14. Kolkman RG, Mulder MJ, Glade CP, et al; Photoacoustic imaging of port-wine stains. Lasers Surg Med. 2008 Mar;40(3):178-82.
  15. Zhao S, Gu Y, Xue P, et al; Imaging port wine stains by fiber optical coherence tomography. J Biomed Opt. 2010 May-Jun;15(3):036020.
  16. Sharif SA, Taydas E, Mazhar A, et al; Noninvasive clinical assessment of port-wine stain birthmarks using current and future optical imaging technology: a review. Br J Dermatol. 2012 Dec;167(6):1215-23. doi: 10.1111/j.1365-2133.2012.11139.x. Epub 2012 Oct 5.
  17. Port-wine stain; Primary Care Dermatology Society, 2014
  18. Mahendran R, Sheehan-Dare RA; Survey of the practices of laser users in the UK in the treatment of port wine stains. J Dermatolog Treat. 2004 Apr;15(2):112-7.
  19. Savas JA, Ledon JA, Franca K, et al; Pulsed dye laser-resistant port-wine stains: mechanisms of resistance and implications for treatment. Br J Dermatol. 2013 May;168(5):941-53. doi: 10.1111/bjd.12204.
  20. Rajaratnam R, Laughlin SA, Dudley D; Pulsed dye laser double-pass treatment of patients with resistant capillary Lasers Med Sci. 2011 Apr 8.
  21. Huang YC, Tran N, Shumaker PR, et al; Blood flow dynamics after laser therapy of port wine stain birthmarks. Lasers Surg Med. 2009 Oct;41(8):563-71.
  22. Hu X, Jiang C, Lin X, et al; Reconstruction of the Cheek after Large Port-Wine Stain Lesion Resection. Aesthetic Plast Surg. 2011 Mar 18.
  23. Tremaine AM, Armstrong J, Huang YC, et al; Enhanced port-wine stain lightening achieved with combined treatment of selective photothermolysis and imiquimod. J Am Acad Dermatol. 2012 Apr;66(4):634-41. doi: 10.1016/j.jaad.2011.11.958. Epub 2012 Jan 14.
  24. Jia W, Aguilar G, Verkruysse W, et al; Improvement of port wine stain laser therapy by skin preheating prior to cryogen spray cooling: a numerical simulation. Lasers Surg Med. 2006 Feb;38(2):155-62.
  25. Sheehan DJ, Lesher JL Jr; Pyogenic granuloma arising within a port-wine stain. Cutis. 2004 Mar;73(3):175-80.
  26. Hansen K, Kreiter CD, Rosenbaum M, et al; Long-term psychological impact and perceived efficacy of pulsed-dye laser therapy Dermatol Surg. 2003 Jan;29(1):49-55.
  27. Fonder MA, Mamelak AJ, Kazin RA, et al; Port-wine-stain-associated dermatitis: implications for cutaneous vascular laser therapy. Pediatr Dermatol. 2007 Jul-Aug;24(4):376-9.
  28. Klein A, Baumler W, Landthaler M, et al; Laser and IPL treatment of port-wine stains: therapy options, limitations, and Lasers Med Sci. 2011 Mar 10.

Disclaimer: This article is for information only and should not be used for the diagnosis or treatment of medical conditions. EMIS has used all reasonable care in compiling the information but make no warranty as to its accuracy. Consult a doctor or other health care professional for diagnosis and treatment of medical conditions. For details see our conditions.

Original Author:
Dr Hayley Willacy
Current Version:
Peer Reviewer:
Dr John Cox
Document ID:
1621 (v25)
Last Checked:
28/04/2014
Next Review:
27/04/2019

Did you find this health information useful?

Yes No

Thank you for your feedback!

Subcribe to the Patient newsletter for healthcare and news updates.

We would love to hear your feedback!

 
 
Patient Access app - find out more Patient facebook page - Like our page